Polymorphisms of PTPN11 Coding SHP-2 as Biomarkers for Ulcerative Colitis Susceptibility in the Japanese Population (original) (raw)

• Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182–205. doi:10.1016/S0016-5085(98)70381-6.
  Article PubMed CAS Google Scholar
• Farrell RJ, Peppercorn MA. Ulcerative colitis. Lancet 2002;359:331–40. doi:10.1016/S0140-6736(02)07499-8.
  Article PubMed Google Scholar
• Yang H, Taylor KD, Rotter JI. Inflammatory bowel disease, I. genetic epidemiology. Mol Genet Metab 2001;74:1–21. doi:10.1006/mgme.2001.3199.
  Article PubMed CAS Google Scholar
• Taylor KD, Yang H, Rotter JI. Inflammatory bowel disease, II. gene mapping. Mol Genet Metab 2001;74:22–44. doi:10.1006/mgme.2001.3214.
  Article PubMed CAS Google Scholar
• Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 2003;124:521–36. doi:10.1053/gast.2003.50045.
  Article PubMed CAS Google Scholar
• Ahmad T, Tamboli CP, Jewell D, Colombel JF. Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology 2004;126:1533–49. doi:10.1053/j.gastro.2004.01.061.
  Article PubMed CAS Google Scholar
• Powrie F. T cells in inflammatory bowel disease: protective and pathogenic role. Immunity 1995;3:171–4. doi:10.1016/1074-7613(95)90086-1.
  Article PubMed CAS Google Scholar
• Blumberg RS, Saubermann LJ, Strober W. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 1999;11:648–56. doi:10.1016/S0952-7915(99)00032-1.
  Article PubMed CAS Google Scholar
• Mizoguchi A, Mizoguchi E, Bhan AK. Immune networks in animal models of inflammatory bowel disease. Inflamm Bowel Dis 2003;9:246–59. doi:10.1097/00054725-200307000-00005.
  Article PubMed Google Scholar
• Machida H, Tsukamoto K, Wen CY, Narumi Y, Shikuwa S, Isomoto H, et al. Association of polymorphic alleles of CTLA4 with inflammatory bowel disease in the Japanese. World J Gastroenterol 2005;11:4188–93.
  PubMed CAS Google Scholar
• Karandikar NJ, Vanderlugt CL, Walunas TL, Miller SD, Bluestone JA. CTLA-4: a negative regulator of autoimmune disease. J Exp Med 1996;184:783–8. doi:10.1084/jem.184.2.783.
  Article PubMed CAS Google Scholar
• Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001;19:225–52. doi:10.1146/annurev.immunol.19.1.225.
  Article PubMed CAS Google Scholar
• Khoury SJ, Sayegh MH. The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity 2004;20:529–38. doi:10.1016/S1074-7613(04)00116-5.
  Article PubMed CAS Google Scholar
• Zhang X, Schwartz JCD, Guo X, Bhatia S, Cao E, Chen L, et al. Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity 2004;20:337–47. doi:10.1016/S1074-7613(04)00051-2.
  Article PubMed CAS Google Scholar
• Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, et al. PD-L2 is a second ligand for PD-1 and inhibit T cell activation. Nat Immunol 2001;2:261–8. doi:10.1038/85330.
  Article PubMed CAS Google Scholar
• Prokunina L, Castillejo-López C, Öberg F, Gunnarsson I, Berg L, Magnusson V, et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002;32:666–9. doi:10.1038/ng1020.
  Article PubMed CAS Google Scholar
• Ferreiros-Vidal I, Gomez-Reino JJ, Barros F, Carracedo A, Carreira P, Gonzalez-Escribano F, et al. Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum 2004;50:2590–7. doi:10.1002/art.20436.
  Article PubMed CAS Google Scholar
• Johansson M, Ärlestig L, Möller B, Rantapää-Dahlqvist S. Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus. Arthritis Rheum 2005;52:1665–9. doi:10.1002/art.21058.
  Article PubMed CAS Google Scholar
• Lin SC, Yen JH, Tsai JJ, Tsai WC, Ou TT, Liu HW, et al. Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus. Arthritis Rheum 2004;50:770–5. doi:10.1002/art.20040.
  Article PubMed CAS Google Scholar
• Kong EKP, Prokunina-Olsson L, Wong WHS, Lau CS, Chan TM, Alarcón-Riquelme M, et al. A new haplotype of PDCD1 is associated with rheumatoid arthritis in Hong Kong Chinese. Arthritis Rheum 2005;52:1058–62. doi:10.1002/art.20966.
  Article PubMed CAS Google Scholar
• Kroner A, Mehling M, Hemmer B, Riechmann P, Toyka KV, Mäurer M, et al. A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 2005;58:50–7. doi:10.1002/ana.20514.
  Article PubMed CAS Google Scholar
• Chuang E, Lee KM, Robbins MD, Duerr JM, Alegre ML, Hambor JE, et al. Regulation of cytotoxic T lymphocyte-associated molecule-4 by src kinases. J Immunol 1999;162:1270–7.
  PubMed CAS Google Scholar
• Schneider H, Rudd CE. Tyrosine phosphatase SHP-2 binding to CTLA-4: absence of direct YVKM/YFIP motif recognition. Biochem Biophys Res Commun 2000;269:279–83. doi:10.1006/bbrc.2000.2234.
  Article PubMed CAS Google Scholar
• Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci USA 2001;98:13866–71. doi:10.1073/pnas.231486598.
  Article PubMed CAS Google Scholar
• Chemnitz JM, Parry RV, Nichols KE, June CH, Riley JL. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol 2004;173:945–54.
  PubMed CAS Google Scholar
• Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 2001;29:465–8. doi:10.1038/ng772.
  Article PubMed CAS Google Scholar
• Digilio MC, Conti E, Sarkozy A, Migarelli R, Dottorini T, Marino B, et al. Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet 2002;71:389–94. doi:10.1086/341528.
  Article PubMed CAS Google Scholar
• Sarkozy A, Conti E, Seripa D, Digilio MC, Grifone N, Tandoi C, et al. Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes. J Med Genet 2003;40:704–8. doi:10.1136/jmg.40.9.704.
  Article PubMed CAS Google Scholar
• Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, et al. Somatic mutations in PTPN11 in juvenile myelomonocyte leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 2003;34:148–50. doi:10.1038/ng1156.
  Article PubMed CAS Google Scholar
• Goto Y, Ando T, Yamamoto K, Tamakoshi A, El-Omar E, Goto H, et al. Association between serum pepsinogens and polymorphism of PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese. Int J Cancer 2006;118:203–8. doi:10.1002/ijc.21338.
  Article PubMed CAS Google Scholar
• Podolsky DK. Inflammatory bowel disease (1). N Engl J Med 1991;325:928–37.
  PubMed CAS Google Scholar
• Podolsky DK. Inflammatory bowel disease (2). N Engl J Med 1991;325:1008–16.
  PubMed CAS Google Scholar
• Mori M, Yamada R, Kobayashi K, Kawaida R, Yamamoto K. Ethnic difference in allele frequency of autoimmune-disease-associated SNPs. J Hum Genet 2005;50:264–6. doi:10.1007/s10038-005-0246-8.
  Article PubMed Google Scholar
• Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005;23:515–48. doi:10.1146/annurev.immunol.23.021704.115611.
  Article PubMed Google Scholar
• Okazaki T, Honjo T. PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol 2007;19:813–24. doi:10.1093/intimm/dxm057.
  Article PubMed CAS Google Scholar
• Heinrich PC, Behrmann I, Müller-Newen G, Schaper F, Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 1998;334:297–314.
  PubMed CAS Google Scholar
• Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 2003;149:1–38. doi:10.1007/s10254-003-0012-2.
  Article PubMed CAS Google Scholar
• Holtkamp W, Stollberg T, Reis HE. Serum interleukin-6 is related to disease activity but not disease specificity in inflammatory bowel disease. J Clin Gastroenterol 1995;20:123–6. doi:10.1097/00004836-199503000-00010.
  Article PubMed CAS Google Scholar
• Mudter J, Weigmann B, Bartsch B, Kiesslich R, Strand D, Galle PR, et al. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am J Gastroenterol 2005;100:64–72. doi:10.1111/j.1572-0241.2005.40615.x.
  Article PubMed CAS Google Scholar
• Carey R, Jurickova I, Ballard E, Bonkowski E, Han X, Xu H, et al. Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease. Inflamm Bowel Dis 2008;14:446–57. doi:10.1002/ibd.20342.
  Article PubMed Google Scholar
• Balding J, Livingstone WJ, Conroy J, Mynett-Johnson L, Weir DG, Mahmund N, et al. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediat Inflamm 2004;13:181–7. doi:10.1080/09511920410001713529.
  Article CAS Google Scholar
• Kwon KH, Murakami A, Hayashi R, Ohigashi H. Interleuikin-1β targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis. Biochem Biophys Res Commun 2005;337:647–54. doi:10.1016/j.bbrc.2005.09.107.
  Article PubMed CAS Google Scholar
• Tartaglia M, Gelb BD. Germ-line and somatic PTPN11 mutations in human disease. Eur J Med Genet 2005;48:81–96. doi:10.1016/j.ejmg.2005.03.001.
  Article PubMed Google Scholar
• Oishi K, Gaengel K, Krishnamoorthy S, Kamiya K, Kim IK, Ying H, et al. Transgenic Drosophila models of Noonan syndrome causing PTPN11 gain-of-function mutations. Hum Mol Genet 2006;15:543–53. doi:10.1093/hmg/ddi471.
  Article PubMed CAS Google Scholar